IGF1R and breast carcinoma: Among these candidate genes, IGF1R was predicted which has been confirmed as a robust oncogene in breast cancer, including TNBC (Klinakis et al., 2009; Castano et al., 2013; Obr et al., 2018; Figure 4A).